I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

MIT engineers have successfully used a machine-learning model to design nanoparticles that can deliver RNA to cells more efficiently. Using artificial intelligence, MIT researchers have come up with a ...

As the world marks World Immunization Week, attention turns once again to the lifesaving power of vaccines. Amid headlines about rising cases of measles, falling vaccination rates and growing vaccine ...

Learn how messenger RNA, spike protein, and lipid nanoparticles drive rapid advances in vaccines and cancer therapies, reshaping modern medicine with precision and speed. Pixabay, spencerbdavis1 ...

Programmable nucleic acid nanoparticles boost vaccine immune responses as effectively as standard adjuvants in mice while avoiding the autoimmune risks that limit existing alternatives. (Nanowerk ...

RNA rewards companies that can integrate biology, data science, manufacturing, and clinical development into a single adaptive engine. Pharma is moving into a new phase of competition one shaped less ...